COMMUNIQUÉS West-GlobeNewswire

-
CloudMD Receives Court Approval of Proposed Transaction with CPS Capital
03/07/2024 -
OPTIMAS Now Available from The Peer Group
03/07/2024 -
Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
03/07/2024 -
Cidara Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
03/07/2024 -
Sharps Technology Receives Purchase Orders for 1 Million SecureGard Syringes for 2024 Delivery
03/07/2024 -
Monthly information related to total number of voting rights and shares composing the share capital – July 1, 2024
03/07/2024 -
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 1er juillet 2024
03/07/2024 -
Boehringer Ingelheim and OSE Immunotherapeutics advance clinical development of first-in-class SIRP cancer immunology treatment BI 770371
03/07/2024 -
OSE Immunotherapeutics et Boehringer Ingelheim poursuivent l’avancée du développement clinique du traitement first-in-class SIRPα BI 770371 en immunologie du cancer
03/07/2024 -
IVI RMA Global and Lavima Fertility join forces in research in fertility treatments
03/07/2024 -
Eurobio Scientific : bilan semestriel du contrat de liquidité
03/07/2024 -
Sharps Technology Urges Shareholders to Approve the Proposals in connection with the Special Meeting on July 15, 2024
03/07/2024 -
Appeal launched to support people impacted by Hurricane Beryl
03/07/2024 -
Lancement d’un fonds de secours en réponse à l’ouragan Béryl
03/07/2024 -
Rafarma pharmaceutical updates: creation of a joint research and production enterprise in Busan (South Korea) between Rafarma and the Korean pharmaceutical company Woods Medical Care
03/07/2024 -
Artelo Biosciences Presents Comparative Data from Key Preclinical Studies on ART12.11 at the 34th Annual International Cannabinoid Research Society Symposium
03/07/2024 -
Autonomix Medical, Inc. (NASDAQ: AMIX) Reviews Positive Results Seen in Pancreatic Cancer Pain Trial in Virtual Investor “What This Means” Segment
03/07/2024 -
AIM ImmunoTech Announces Release of the Next CEO Corner Segment
03/07/2024 -
The International Myeloma Foundation Thanks Dr. Brian G.M. Durie for 35 Years of Remarkable Leadership
03/07/2024
Pages